
Sophia Genetics rose 84.0% from $4.05 to $7.45, ahead of the S&P 500's +10.0%. Its worst day was Mar 3 (−11.3%), and its low came Nov 20 at $3.89.
Nov 17, 2025 – Nov 17, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Sophia Genetics closed at its lowest level of the year, 4.0% below where the year started.
−3.0% · S&P 500 −1.5%
EPS of $-0.28 missed the $-0.20 estimate on $21.7M revenue (est. $20.9M); FY revenue guidance of $92.0M–$94.0M against the $88.7M consensus.
Story events cover the past 12 months · Times ET
−11.3%, the year's worst day · S&P 500 −0.9%
EPS of $-0.27 missed the $-0.24 estimate on $21.7M revenue (est. $20.4M); FY revenue guidance of $92.0M–$94.0M against the $93.3M consensus.
−4.2% · S&P 500 +0.8%
EPS of $-0.30 missed the $-0.22 estimate on $23.3M revenue (est. $21.6M); FY revenue guidance of $94.0M–$96.0M against the $93.4M consensus.
+20.2%, the year's best day · S&P 500 +1.8%
Sophia Genetics closed at its highest level of the year, 120.2% above where the year started.
+4.6% · S&P 500 +0.7%
Sophia Genetics shares fell 10.0%, while the S&P 500 rose 0.5%.
−10.0% · S&P 500 +0.5%
EPS of $-0.24 missed the $-0.19 estimate on $24.3M revenue (est. $24.0M); FY revenue guidance of $96.0M against the $95.2M consensus.
−2.8% · S&P 500 +0.3%
Where it ended: a close of $7.45 on Nov 17, 2026. Up next: Q4 2026 earnings on Mar 2, 2027 (EPS est. $-0.15, revenue est. $26.3M).
Nothing in the past 12 months.
All SOPH dividend historyReplay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for SOPH and SPY from Benzinga historical bars. Not investment advice.